--Morgan Stanley Adjusts Price Target on Guardant Health to $60 From $66, Maintains Overweight Rating

--Morgan Stanley Adjusts Price Target on Guardant Health to $60 From $66, Maintains Overweight Rating

MT Newswires · 05/11/2023 05:06

Please log in to view news